EXHIBIT 11.1
GENERAL SURGICAL INNOVATIONS, INC. AND SUBSIDIARY
COMPUTATION OF NET LOSS PER SHARE (1) (2)
(In thousands, expect per share data)
Quarter Ended March 31, Nine Months Ended March 31,
----------------------------------- -----------------------------------
1997 1996 1997 1996
------------ -------------- -------------- -------------
Primary and Fully Diluted:
Weighted average common shares........ 13,211 3,356 13,181 3,355
Common and common equivalent shares
pursuant to Staff Accounting
Bulletin No. 63...................... 3,201 3,201
------------ -------------- -------------- -------------
Shares used in per share calculation.... 13,211 6,557 13,181 6,556
------------ -------------- -------------- -------------
------------ -------------- -------------- -------------
Net loss................................ $ (439) $(3,372) $ (905) $ (5,435)
------------ -------------- -------------- -------------
------------ -------------- -------------- -------------
Net loss per share...................... $ (0.03) $ (0.51) $ (0.07) $ (0.83)
------------ -------------- -------------- -------------
------------ -------------- -------------- -------------
- -------------------
(1) There is no difference between primary and fully diluted net loss per share
for all periods presented.
(2) This schedule contains summary financial information extracted from the
consolidated balance sheets and consolidated statements of operations found
on pages 3 and 4 of the Company's form 10-Q for the year-to-date, and is
qualified in its entirety by reference to such financial statements.